<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Hosp Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Hosp Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">3587</journal-id><journal-id journal-id-type="pmc-domain">ejhp</journal-id><journal-id journal-id-type="publisher-id">ejhp</journal-id><journal-title-group><journal-title>European Journal of Hospital Pharmacy</journal-title></journal-title-group><issn pub-type="ppub">2047-9956</issn><issn pub-type="epub">2047-9964</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8899638</article-id><article-id pub-id-type="pmcid-ver">PMC8899638.1</article-id><article-id pub-id-type="pmcaid">8899638</article-id><article-id pub-id-type="pmcaiid">8899638</article-id><article-id pub-id-type="pmid">34764144</article-id><article-id pub-id-type="doi">10.1136/ejhpharm-2021-003089</article-id><article-id pub-id-type="publisher-id">ejhpharm-2021-003089</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>2343</subject></subj-group></article-categories><title-group><article-title>Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis</article-title></title-group><contrib-group><contrib id="author-87711904" contrib-type="author"><name name-style="western"><surname>Shahrami</surname><given-names initials="B">Bita</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib id="author-87711907" contrib-type="author"><name name-style="western"><surname>Sefidani Forough</surname><given-names initials="A">Aida</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib id="author-74080778" contrib-type="author"><name name-style="western"><surname>Khezrnia</surname><given-names initials="SS">Seyedeh Sana</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib id="author-87711906" contrib-type="author"><name name-style="western"><surname>Najmeddin</surname><given-names initials="F">Farhad</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib id="author-87711905" contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9594-5522</contrib-id><name name-style="western"><surname>Arabzadeh</surname><given-names initials="AA">Amir Ahmad</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib id="author-78911371" contrib-type="author"><name name-style="western"><surname>Rouini</surname><given-names initials="MR">Mohammad Reza</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib id="author-87711908" contrib-type="author"><name name-style="western"><surname>Najafi</surname><given-names initials="A">Atabak</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib id="author-87711598" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2160-9301</contrib-id><name name-style="western"><surname>Mojtahedzadeh</surname><given-names initials="M">Mojtaba</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution content-type="department">Department of Clinical Pharmacy</institution>, <institution>Tehran University of Medical Sciences</institution>, <addr-line content-type="city">Tehran</addr-line>, <country>The Islamic Republic of Iran</country>
</aff><aff id="aff2">
<label>2</label>
<institution content-type="department">School of Clinical Sciences, Faculty of Health</institution>, <institution>Queensland University of Technology</institution>, <addr-line content-type="city">Brisbane</addr-line>, <addr-line content-type="state">Queensland</addr-line>, <country>Australia</country>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="department">Department of Surgery</institution>, <institution>Ardabil University of Medical Sciences</institution>, <addr-line content-type="city">Ardabil</addr-line>, <country>The Islamic Republic of Iran</country>
</aff><aff id="aff4">
<label>4</label>
<institution content-type="department">Department of Pharmaceutics</institution>, <institution>Tehran University of Medical Sciences</institution>, <addr-line content-type="city">Tehran</addr-line>, <country>The Islamic Republic of Iran</country>
</aff><aff id="aff5">
<label>5</label>
<institution content-type="department">Department of Anesthesiology and Critical Care</institution>, <institution>Tehran University of Medical Sciences</institution>, <addr-line content-type="city">Tehran</addr-line>, <country>The Islamic Republic of Iran</country>
</aff><author-notes><corresp><label>Correspondence to</label> Professor Mojtaba Mojtahedzadeh, Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, The Islamic Republic of Iran; <email>mojtahed@sina.tums.ac.ir</email></corresp><fn fn-type="other" id="fn7"><p>EAHP Statement 4: Clinical Pharmacy Services.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2021</year></pub-date><volume>29</volume><issue>e1</issue><issue-id pub-id-type="pmc-issue-id">402494</issue-id><fpage>e72</fpage><lpage>e76</lpage><history><date date-type="received"><day>02</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-23 20:25:40.933"><day>23</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2022</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ejhpharm-2021-003089.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="ejhpharm-2021-003089.pdf"/><abstract><sec><title>Objectives</title><p>This study aimed to evaluate the relationship between amikacin pharmacokinetics and the biomarkers associated with organ dysfunction in critically ill patients with intra-abdominal sepsis.</p></sec><sec><title>Methods</title><p>A case series involving critically ill patients with intra-abdominal sepsis who received an amikacin loading dose of 20&#8211;25&#8201;mg/kg intravenous infusion was studied. The 1-, 2-, 4-, 6- and 24-hour amikacin serum concentrations were measured to calculate the pharmacokinetic parameters. The Sequential Organ Failure Assessment (SOFA) score, white blood cells, neutrophil to lymphocyte ratio, platelet count, serum creatinine, creatinine clearance, bilirubin, partial pressure of oxygen to fraction of inspired oxygen ratio, serum albumin, procalcitonin, lactate level, erythrocyte sedimentation rate (ESR) and C-reactive protein were recorded. A linear regression analysis was performed to examine the relationship between the amikacin pharmacokinetics and the biological parameters.</p></sec><sec><title>Results</title><p>Twenty-one patients were studied. A significant correlation was found between the volume of distribution and ESR (p&lt;0.05, r=0.844). Moreover, drug clearance had a significant inverse correlation with serum lactate (p&lt;0.05, r=&#8722;0.603). No other significant correlations were found.</p></sec><sec><title>Conclusions</title><p>ESR and serum lactate were identified as useful predictors of amikacin pharmacokinetics in critically ill patients with intra-abdominal sepsis and may help guide the selection of appropriate empirical dosing.</p></sec></abstract><kwd-group><kwd>pharmacokinetics</kwd><kwd>critical care</kwd><kwd>drug monitoring</kwd><kwd>pharmacology</kwd><kwd>emergency medicine</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="funding-1"><funding-source><institution-wrap><institution>TUMS</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>